Clinical Trials Directory

Trials / Sponsors / Depomed

Depomed

Industry · 14 registered clinical trials.

StatusTrialPhaseStarted
CompletedSimulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin
Healthy
Phase 42015-09-24
CompletedPharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds
Migraine
Phase 42015-01-01
CompletedOpen Label Crossover Study Pharmacokinetics (PK) Study in Healthy Volunteers Receiving Various Forms of Fentan
Healthy
Phase 42014-11-01
CompletedPharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acu
Pain
Phase 42014-09-01
CompletedSafety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute
Pain
Phase 42013-11-01
CompletedStudy in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
Parkinson's Disease, Motor Fluctuations
Phase 22012-01-01
CompletedPhase IV Study of FDA Approved, Once-Daily GRALISE™(Gabapentin) Tablets for the Treatment of Postherpetic Neur
Post Herpetic Neuralgia
—2011-09-01
CompletedBreeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopau
Hot Flashes
Phase 32010-08-01
CompletedStudy of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in
Hot Flashes
Phase 32008-10-01
CompletedStudy of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms i
Hot Flashes
Phase 32008-09-01
CompletedSafety and Efficacy of Gabapentin in Postherpetic Neuralgia
Neuralgia,Postherpetic
Phase 32008-03-01
CompletedStudy of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms i
Hot Flashes
Phase 22007-06-01
CompletedSafety and Efficacy of Gabapentin in Postherpetic Neuralgia
Neuralgia, Postherpetic
Phase 32006-05-01
CompletedSafety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathy
Phase 22006-04-01